Überwachung der COVID-19-Impfstoffe durch das Paul-Ehrlich-Institut vor dem Jahr 2022

This question asks about the oversight activities of the Paul-Ehrlich-Institut concerning COVID-19 vaccines before 2022. It seeks to understand the regulatory processes in place for vaccine safety and efficacy. The information requested is relevant to public health and the public's trust in vaccination programs. It affects citizens, healthcare providers, and pharmaceutical companies involved in vaccine development and distribution.